Cesca Therapeutics Inc (KOOL)

3.18
0.01 0.29
NASDAQ : Health Care
Prev Close 3.17
Open 3.24
Day Low/High 3.18 / 3.45
52 Wk Low/High 1.64 / 15.40
Volume 11.88K
Avg Volume 97.60K
Exchange NASDAQ
Shares Outstanding 9.90M
Market Cap 33.08M
EPS -7.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cesca Therapeutics Acquires The Cell Processing Systems Of SynGen Under Asset Acquisition Agreement

Cesca Therapeutics Acquires The Cell Processing Systems Of SynGen Under Asset Acquisition Agreement

Combined product portfolio strengthens Cesca's position as a leading developer of systems for automated manufacturing of cell-based therapeutics in immuno-oncology and other indications

Cesca Therapeutics To Announce Fiscal Third Quarter 2017 Financial Results On May 11, 2017

Conference Call to be Held at 4:30 p.m. EDT (1:30 p.m. PDT)

Cesca Therapeutics Highlights Promising Data For The Treatment Of Chronic Non-Healing Ulcers

Significant reduction in wound size observed in all treated patients using autologous platelet rich plasma

Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results And Provides Business Update

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Therapeutics Reports First Quarter Fiscal 2017 Results And Provides Business Update

Cesca Therapeutics Reports First Quarter Fiscal 2017 Results And Provides Business Update

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Therapeutics Reports Fourth Quarter And Fiscal 2016 Year End Results

Cesca Therapeutics Reports Fourth Quarter And Fiscal 2016 Year End Results

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Therapeutics Granted Two Patents For Rapid Infusion Of Autologous Bone Marrow Derived Stem Cells

Cesca Therapeutics Granted Two Patents For Rapid Infusion Of Autologous Bone Marrow Derived Stem Cells

Technology Fundamental to Cesca's Proprietary SurgWerks™ Platform for CLI and AMI